Anti-TR13B/ TNFRSF13B/ CD267 monoclonal antibody

Anti-TR13B/ TNFRSF13B/ CD267 antibody for FACS & in-vivo assay

Target products collectionGo to TNFRSF13B/TNFRSF13B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T99394-Ab-1/ GM-Tg-hg-T99394-Ab-2Anti-Human TNFRSF13B monoclonal antibodyHuman
GM-Tg-rg-T99394-Ab-1/ GM-Tg-rg-T99394-Ab-2Anti-Rat TNFRSF13B monoclonal antibodyRat
GM-Tg-mg-T99394-Ab-1/ GM-Tg-mg-T99394-Ab-2Anti-Mouse TNFRSF13B monoclonal antibodyMouse
GM-Tg-cynog-T99394-Ab-1/ GM-Tg-cynog-T99394-Ab-2Anti-Cynomolgus/ Rhesus macaque TNFRSF13B monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T99394-Ab-1/ GM-Tg-felg-T99394-Ab-2Anti-Feline TNFRSF13B monoclonal antibodyFeline
GM-Tg-cang-T99394-Ab-1/ GM-Tg-cang-T99394-Ab-2Anti-Canine TNFRSF13B monoclonal antibodyCanine
GM-Tg-bovg-T99394-Ab-1/ GM-Tg-bovg-T99394-Ab-2Anti-Bovine TNFRSF13B monoclonal antibodyBovine
GM-Tg-equg-T99394-Ab-1/ GM-Tg-equg-T99394-Ab-2Anti-Equine TNFRSF13B monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T99394-Ab-1/ GM-Tg-hg-T99394-Ab-2; GM-Tg-rg-T99394-Ab-1/ GM-Tg-rg-T99394-Ab-2;
GM-Tg-mg-T99394-Ab-1/ GM-Tg-mg-T99394-Ab-2; GM-Tg-cynog-T99394-Ab-1/ GM-Tg-cynog-T99394-Ab-2;
GM-Tg-felg-T99394-Ab-1/ GM-Tg-felg-T99394-Ab-2; GM-Tg-cang-T99394-Ab-1/ GM-Tg-cang-T99394-Ab-2;
GM-Tg-bovg-T99394-Ab-1/ GM-Tg-bovg-T99394-Ab-2; GM-Tg-equg-T99394-Ab-1/ GM-Tg-equg-T99394-Ab-2
Products NameAnti-TNFRSF13B monoclonal antibody
Formatmab
Target NameTNFRSF13B
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-TNFRSF13B benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species TR13B/ TNFRSF13B/ CD267 VLP (virus-like particle) (Products Developing)
    CytokineGM-Tg-g-T99394-Ag-1tumor necrosis factor receptor superfamily, member 13B (TNFRSF13B) protein


    Target information

    Target IDGM-T99394
    Target NameTNFRSF13B
    Gene ID23495,57916,103693341,574200,609580,101089305,617948,100051166
    Gene Symbol and Synonyms1200009E08Rik,CD267,CVID,CVID2,IGAD2,NF-AT,RYZN,TACI,TNFRSF13B,TNFRSF14B
    Uniprot AccessionO14836
    Uniprot Entry NameTR13B_HUMAN
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target, Immuno-oncology Target, Cytokine Target
    DiseaseN/A
    Gene EnsemblENSG00000240505
    Target ClassificationCheckpoint-Immuno Oncology

    The target: TNFRSF13B, gene name: TNFRSF13B, also named as CD267, CVID, CVID2, IGAD2, RYZN, TACI, TNFRSF14B. The protein encoded by this gene is a lymphocyte-specific member of the tumor necrosis factor (TNF) receptor superfamily. It interacts with calcium-modulator and cyclophilin ligand (CAML). The protein induces activation of the transcription factors NFAT, AP1, and NF-kappa-B and plays a crucial role in humoral immunity by interacting with a TNF ligand. This gene is located within the Smith-Magenis syndrome region on chromosome 17. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.